Alessandra Daigneault
General Counsel
NRX Pharmaceuticals, Inc. (NRXP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alessandra Daigneault
Alessandra Daigneault is recorded as General Counsel at NRX Pharmaceuticals, Inc. (NRXP). NRX Pharmaceuticals, Inc. reported in an 8-K filed July 28, 2022 that Alessandra Daigneault resigned as Chief Corporate Officer, General Counsel and Corporate Secretary, effective July 22, 2022.
“On July 22, 2022, Ms. Alessandra Daigneault resigned as Chief Corporate Officer, General Counsel and Corporate Secretary of NRx Pharmaceuticals, Inc. (the "Company"), effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-05-24–present
-
Start not stated–2022-07-22
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at NRX Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Jonathan C. Javitt CEO, Chairman, Board Member
- Jonathan Javitt CEO, Chairman
- Stephen Willard CEO
- Bennett Kim CFO, Board Member
- Dr. Seth Van Voorhees CFO
- Ira Strassberg CFO
- Michael Abrams CFO
- William Fricker CFO
- Joseph Casper COO
- Joseph M. Casper COO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.